Evidence map›Paper›PMID 36497458›Full record

ArticleCancers2022

Scabertopin Derived from

Yuanhui Gao, Zhenyu Nie, Hui Cao, Denggao Huang, Mei Chen, Yang Xiang, Xiaolong Yu, Shufang Zhang

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Ethyl acetate extract ofResearch in pharmaceutical sciences · 2026
    Article
  2. The Role of Natural Compounds in Bladder Urothelial Carcinoma Treatment.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuanhui GaoCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Zhenyu NieCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.ORCID 0000-0003-2172-7957
Hui CaoCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Denggao HuangCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Mei ChenCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Yang XiangCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Xiaolong YuSchool of Materials Science and Engineering, Hainan University, Haikou 570228, China.
Shufang ZhangCentral Laboratory, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 570208, China.
Central South University · CNHainan University · CN

Funding

Health Industry Scientific Research Project of Hainan Province 21A200412National Nature Science Foundation of China 82160531Science and Technology Project of Hainan 820QN423, 821QN424 and ZDYF2021SHFZ096
6 · The paper itself

Abstract

Bladder cancer remains one of the most common malignant tumors that threatens human health worldwide. It imposes a heavy burden on patients and society due to the high medical costs associated with its easy metastasis and recurrence. Although several treatment options for bladder cancer are available, their clinical efficacy remains unsatisfactory. Therefore, actively exploring new drugs and their mechanisms of action for the clinical treatment of bladder cancer is very important. Scabertopin is one of the major sesquiterpene lactones found in

Indexed as

bladder cancerElephantopus scaber L.necroptosisreactive oxygen speciesscabertopin

Identifiers

PMID36497458
PMCPMC9738305
OpenAlexW4311287833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.